CJC-1295 With DAC vs Ipamorelin: Research Comparison
A Side-By-Side Research Comparison Of CJC-1295 With DAC And Ipamorelin - a GHRH analog versus a selective ghrelin-receptor secretagogue. This Reference Compares Mechanism, Evidence Tier, Molecular Identity, And Pharmacokinetics For Qualified Researchers. For In Vitro Laboratory Research Use Only. Not Medical Advice Or Dosing Guidance.
Side-By-Side Comparison
| CJC-1295 With DAC | Ipamorelin | |
|---|---|---|
| Category | Muscle Growth & Performance | Muscle Growth & Performance |
| Compound Class | Long-acting synthetic GHRH analog with Drug Affinity Complex (DAC) albumin-binding moiety | Selective synthetic pentapeptide GH secretagogue (GHRP); minimal cortisol/prolactin side effects |
| Evidence Tier | Research Compound | Research Compound |
| Molecular Target | GHRH receptor (GHRHR) on pituitary somatotrophs; sustained GH and IGF-1 elevation | GHS-R1a (ghrelin receptor) agonist; highly selective for pituitary GH release without significant ACTH/cortisol elevation |
| Molecular Weight | 3647.1 Da | 711.85 Da |
| Amino Acid Sequence | tetrasubstituted GRF(1-29) + DAC | Aib-His-D-2-Nal-D-Phe-Lys-NH2 |
| CAS Number | 446262-90-4 | 170851-70-4 |
| Half-Life | ~6-8 days (albumin-bound, DAC) | ~2 hours |
| Studied For | GH pulsatile release research, GH-axis anti-aging, Growth hormone deficiency, Extended GH secretion | GH secretagogue research, Anti-aging / longevity via GH axis, Body composition improvement, Lean muscle gain |
About CJC-1295 With DAC
A long-acting growth-hormone-releasing peptide; banned in sport.
Read The Full CJC-1295 With DAC MonographAbout Ipamorelin
A selective, clean growth-hormone-releasing peptide; banned in sport.
Read The Full Ipamorelin MonographKey Differences
- Reported half-life differs: CJC-1295 With DAC at ~6-8 days (albumin-bound, DAC) versus Ipamorelin at ~2 hours.
- Primary molecular target differs: CJC-1295 With DAC acts on GHRH receptor (GHRHR) on pituitary somatotrophs; sustained GH and IGF-1 elevation; Ipamorelin acts on GHS-R1a (ghrelin receptor) agonist; highly selective for pituitary GH release without significant ACTH/cortisol elevation.
Continue Researching
CJC-1295 With DAC · Ipamorelin · Compare Tool · Research Library
This Comparison Is Provided For In Vitro Laboratory Research Use Only. Not For Human Consumption, Diagnosis, Or Treatment. See The Full Research Disclaimer.